Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Collagenase 3 | ||
Ligand | BDBM50305857 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | ChEMBL_605223 (CHEMBL1069934) | ||
Ki | 0.620000±n/a nM | ||
Citation | Schnute, ME; O'Brien, PM; Nahra, J; Morris, M; Howard Roark, W; Hanau, CE; Ruminski, PG; Scholten, JA; Fletcher, TR; Hamper, BC; Carroll, JN; Patt, WC; Shieh, HS; Collins, B; Pavlovsky, AG; Palmquist, KE; Aston, KW; Hitchcock, J; Rogers, MD; McDonald, J; Johnson, AR; Munie, GE; Wittwer, AJ; Man, CF; Settle, SL; Nemirovskiy, O; Vickery, LE; Agawal, A; Dyer, RD; Sunyer, T Discovery of (pyridin-4-yl)-2H-tetrazole as a novel scaffold to identify highly selective matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis. Bioorg Med Chem Lett20:576-80 (2010) [PubMed] Article | ||
More Info.: | Get all data from this article, Assay Method | ||
Collagenase 3 | |||
Name: | Collagenase 3 | ||
Synonyms: | MMP-13 | MMP13 | MMP13_HUMAN | Matrix metalloproteinase-13 | Matrix metalloproteinase-13 (MMP-13) | Matrix metalloproteinase-13 (MMP13) | ||
Type: | Enzyme | ||
Mol. Mass.: | 53808.06 | ||
Organism: | Homo sapiens (Human) | ||
Description: | P45452 | ||
Residue: | 471 | ||
Sequence: |
| ||
BDBM50305857 | |||
n/a | |||
Name | BDBM50305857 | ||
Synonyms: | CHEMBL594932 | trans-4-((5-(2-(4-fluoro-3-(trifluoromethyl)benzylcarbamoyl)-6-methylpyridin-4-yl)-2H-tetrazol-2-yl)methyl)cyclohexanecarboxylic acid | ||
Type | Small organic molecule | ||
Emp. Form. | C24H24F4N6O3 | ||
Mol. Mass. | 520.4794 | ||
SMILES | Cc1cc(cc(n1)C(=O)NCc1ccc(F)c(c1)C(F)(F)F)-c1nnn(C[C@H]2CC[C@@H](CC2)C(O)=O)n1 |r,wU:30.35,wD:27.28,(30.42,-38.58,;29.63,-37.25,;30.37,-35.91,;29.59,-34.59,;28.04,-34.61,;27.29,-35.95,;28.08,-37.28,;25.75,-35.97,;24.99,-37.31,;24.96,-34.65,;23.42,-34.67,;22.63,-33.34,;23.38,-32,;22.6,-30.68,;21.06,-30.7,;20.27,-29.38,;20.3,-32.05,;21.09,-33.37,;18.76,-32.08,;17.97,-30.75,;18.02,-33.42,;17.22,-32.07,;30.34,-33.25,;29.7,-31.84,;30.83,-30.8,;32.17,-31.55,;33.57,-30.91,;34.92,-31.65,;34.94,-33.19,;36.28,-33.94,;37.6,-33.15,;37.57,-31.6,;36.23,-30.86,;38.96,-33.9,;38.98,-35.43,;40.28,-33.1,;31.87,-33.06,)| | ||
Structure |